Evan E. Opas
Impact in
- Biochemistry top 0.5%
- Eicosanoids and Hypertension Pharmacology
- Pharmacology top 1%
- Inflammatory mediators and NSAID effects
Papers in
-
- Eicosanoids and Hypertension Pharmacology 6
- Pharmacology 10
- Inflammatory mediators and NSAID effects 10
- Co-authors
- John L. Humes (11 shared papers)Ronald E. Diehl (1 shared paper)Richard A. F. Dixon (1 shared paper)Philip J. Vickers (1 shared paper)John W. Gillard (1 shared paper)Jilly F. Evans (1 shared paper)Elaine Rands (1 shared paper)Maurice B. Feinstein (2 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (6 papers)Biochemical Pharmacology (4 papers)Maturitas (3 papers)Journal of Biological Chemistry (3 papers)Bone (2 papers)
- Partner nations
- United StatesCanadaJapan
In The Last Decade
Evan E. Opas
40 papers receiving 2.3k citations
Evan E. Opas's Hit Papers
Peers
Comparison fields: 5 of 96
- Biochemistry 554
- Pharmacology 661
- Orthopedics and Sports Medicine 316
- Oncology 304
- Immunology 178
Countries citing papers authored by Evan E. Opas
This map shows the geographic impact of Evan E. Opas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evan E. Opas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evan E. Opas more than expected).
Fields of papers citing papers by Evan E. Opas
This network shows the impact of papers produced by Evan E. Opas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evan E. Opas. The network helps show where Evan E. Opas may publish in the future.
Co-authors
The 25 scholars most cited alongside Evan E. Opas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis Hit paper breakdown → | 1990 | 666 |
| 2 | 1993 | 348 | |
| 3 | 1989 | 296 | |
| 4 | 1996 | 178 | |
| 5 | 1981 | 139 | |
| 6 | 1985 | 113 | |
| 7 | 1999 | 80 | |
| 8 | 1983 | 73 | |
| 9 | 2014 | 71 | |
| 10 | 1986 | 57 | |
| 11 | 1996 | 55 | |
| 12 | 2010 | 51 | |
| 13 | Lipoxygenase pathways of macrophages. | 1985 | 41 |
| 14 | 1997 | 31 | |
| 15 | 2005 | 30 | |
| 16 | 1988 | 25 | |
| 17 | 1991 | 25 | |
| 18 | 1987 | 23 | |
| 19 | 2004 | 23 | |
| 20 | 2011 | 20 |
About Evan E. Opas
Evan E. Opas is a scholar working on Biochemistry, Pharmacology, Oncology, Molecular Biology and Orthopedics and Sports Medicine, having authored 40 papers that have together received 2.6k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (10 papers), Chemokine receptors and signaling (7 papers), Eicosanoids and Hypertension Pharmacology (6 papers), Bone Metabolism and Diseases (4 papers), Synthesis and biological activity (4 papers), Estrogen and related hormone effects (4 papers), Bone health and osteoporosis research (3 papers) and Protein Tyrosine Phosphatases (3 papers). The work is most often cited by research in Biochemistry (554 citations), Pharmacology (661 citations), Orthopedics and Sports Medicine (316 citations), Oncology (304 citations) and Immunology (178 citations). Evan E. Opas has collaborated with scholars based in United States, Canada and Japan. Frequent co-authors include John L. Humes, Ronald E. Diehl, Richard A. F. Dixon, Philip J. Vickers, John W. Gillard, Jilly F. Evans, Elaine Rands, Maurice B. Feinstein, Robert J. Bonney and Gideon A. Rodan. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Biochemical Pharmacology, Maturitas, Journal of Biological Chemistry and Bone.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.